[Federal Register Volume 74, Number 54 (Monday, March 23, 2009)]
[Notices]
[Page 12134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-6220]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Acceptability, Feasibility and Validity of 
Genital Self-Sampling for HPV Among Men, PEP 2009-R-01

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 10 a.m.-12 p.m., May 18, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Acceptability, Feasibility and 
Validity of Genital Self-Sampling for HPV Among Men, PEP 2009-R-
01.''
    Contact Person for More Information: Linda Shelton, Public 
Health Analyst, Coordinating Center for Health and Information 
Service, Office of the Director, CDC, 1600 Clifton Road, NE., 
Mailstop E21, Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 6, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E9-6220 Filed 3-20-09; 8:45 am]
BILLING CODE 4163-18-P